49.79
price down icon0.40%   -0.20
after-market After Hours: 49.79
loading

Ptc Therapeutics Inc Stock (PTCT) Latest News

pulisher
Feb 06, 2025

Rett Syndrome Market Growth Projections 2024-2034: - openPR

Feb 06, 2025
pulisher
Feb 05, 2025

PTC Therapeutics' SWOT analysis: stock poised for growth amid regulatory challenges - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

Cantor Fitzgerald Issues Negative Estimate for PTCT Earnings - MarketBeat

Feb 05, 2025
pulisher
Feb 04, 2025

Duchenne Muscular Dystrophy Market Report 2034: Epidemiology - openPR

Feb 04, 2025
pulisher
Feb 04, 2025

PTC Therapeutics price target raised to $113 from $76 at Cantor Fitzgerald - Yahoo Finance

Feb 04, 2025
pulisher
Feb 04, 2025

PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last? - Yahoo Finance

Feb 04, 2025
pulisher
Feb 03, 2025

PTC Therapeutics rises 9% after Cantor raises price target to Street high - MSN

Feb 03, 2025
pulisher
Feb 03, 2025

Why PTC Therapeutics (PTCT) Stock Is Rallying Today - Insider Monkey

Feb 03, 2025
pulisher
Feb 03, 2025

PTC Therapeutics (NASDAQ:PTCT) Trading Up 6.1% on Analyst Upgrade - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

PTC Therapeutics (NASDAQ:PTCT) Price Target Raised to $113.00 - MarketBeat

Feb 03, 2025
pulisher
Feb 03, 2025

Cantor Fitzgerald lifts PTC Therapeutics stock target to $113 By Investing.com - Investing.com Australia

Feb 03, 2025
pulisher
Feb 03, 2025

Cantor Fitzgerald lifts PTC Therapeutics stock target to $113 - MSN

Feb 03, 2025
pulisher
Jan 30, 2025

Cowen raises PTC Therapeutics stock price target to $50 - MSN

Jan 30, 2025
pulisher
Jan 29, 2025

Cowen raises PTC Therapeutics stock price target to $50 By Investing.com - Investing.com Nigeria

Jan 29, 2025
pulisher
Jan 27, 2025

(PTCT) Technical Data - Stock Traders Daily

Jan 27, 2025
pulisher
Jan 26, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $55.00 Consensus PT from Analysts - Defense World

Jan 26, 2025
pulisher
Jan 25, 2025

PTCT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into PTC Therapeutics, Inc and Encourages Investors to Contact the Firm Today! - ACCESS Newswire

Jan 25, 2025
pulisher
Jan 23, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat

Jan 23, 2025
pulisher
Jan 23, 2025

Analysts Issue Forecasts for PTCT FY2025 Earnings - Defense World

Jan 23, 2025
pulisher
Jan 23, 2025

What is Leerink Partnrs’ Forecast for PTCT FY2024 Earnings? - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

What is Leerink Partnrs' Estimate for PTCT FY2024 Earnings? - MarketBeat

Jan 22, 2025
pulisher
Jan 18, 2025

PTC Therapeutics Stock Soars on Novartis Licensing Agreement - MSN

Jan 18, 2025
pulisher
Jan 18, 2025

Assenagon Asset Management S.A. Sells 52,794 Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT) - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

FY2024 EPS Estimates for PTCT Lifted by Cantor Fitzgerald - Defense World

Jan 18, 2025
pulisher
Jan 17, 2025

William Blair Lifts Earnings Estimates for PTC Therapeutics - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

Gastroparesis Pipeline Trends 2024: Clinical Trials, Therapeutic Innovations, and FDA Approvals | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda, Neurogastrx, Inc, PTC Thera - The Globe and Mail

Jan 16, 2025
pulisher
Jan 16, 2025

William Blair Boosts Earnings Estimates for PTC Therapeutics - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

PTC Therapeutics' SWOT analysis: rare disease biotech stock faces pivotal year - Investing.com Australia

Jan 16, 2025
pulisher
Jan 15, 2025

Cantor Fitzgerald Issues Pessimistic Forecast for PTC Therapeutics (NASDAQ:PTCT) Stock Price - MarketBeat

Jan 15, 2025
pulisher
Jan 14, 2025

PTC Therapeutics sees several potential catalysts in 2025 - MSN

Jan 14, 2025
pulisher
Jan 14, 2025

Orsini the Exclusive Specialty Pharmacy Provider for Gene Therapy KEBILIDI™ (eladocagene exuparvovec-tneq) - Yahoo Finance

Jan 14, 2025
pulisher
Jan 14, 2025

Muscular Dystrophy Treatment Market Next Big Thing Forecast By 2031 | Santhera Pharmaceuticals, PTC Therapeutics - openPR

Jan 14, 2025
pulisher
Jan 13, 2025

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jan 13, 2025
pulisher
Jan 13, 2025

PTC Therapeutics Surpasses Revenue Guidance for 2024 - TipRanks

Jan 13, 2025
pulisher
Jan 13, 2025

PTC Therapeutics reports $814 million in 2024 revenue, surpassing goals - Investing.com

Jan 13, 2025
pulisher
Jan 13, 2025

PTC Therapeutics reports $814 million in 2024 revenue, surpassing goals By Investing.com - Investing.com South Africa

Jan 13, 2025
pulisher
Jan 13, 2025

PTC Therapeutics Provides Update on Commercial Performance and R&D Pipeline at 43rd Annual J.P. Morgan Healthcare Conference - Longview News-Journal

Jan 13, 2025
pulisher
Jan 11, 2025

Ptc Therapeutics' chief accounting officer sells $132,492 in stock - Investing.com India

Jan 11, 2025
pulisher
Jan 11, 2025

Ptc Therapeutics' chief accounting officer sells $132,492 in stock By Investing.com - Investing.com South Africa

Jan 11, 2025
pulisher
Jan 11, 2025

PTC Therapeutics CEO Eric Pauwels sells $167,550 in stock By Investing.com - Investing.com South Africa

Jan 11, 2025
pulisher
Jan 11, 2025

Ptc Therapeutics exec VP sells shares worth $158,870 By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 11, 2025

Ptc Therapeutics CEO Matthew Klein sells $204,007 in stock - Investing.com India

Jan 11, 2025
pulisher
Jan 11, 2025

Ptc Therapeutics CEO Matthew Klein sells $204,007 in stock By Investing.com - Investing.com Australia

Jan 11, 2025
pulisher
Jan 10, 2025

Ptc Therapeutics exec VP sells shares worth $158,870 - Investing.com India

Jan 10, 2025
pulisher
Jan 10, 2025

Ptc therapeutics' EVP sells $90,036 in stock By Investing.com - Investing.com Australia

Jan 10, 2025
pulisher
Jan 10, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) EVP Lee Scott Golden Sells 810 Shares - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) VP Sells 1,543 Shares of Stock - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Christine Marie Utter Sells 1,291 Shares - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

PTC Therapeutics, Inc. (NASDAQ:PTCT) Insider Neil Gregory Almstead Sells 1,265 Shares - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Ptc therapeutics’ EVP sells $90,036 in stock By Investing.com - Investing.com Nigeria

Jan 10, 2025
pulisher
Jan 10, 2025

PTC Therapeutics CEO Eric Pauwels sells $167,550 in stock - Investing.com

Jan 10, 2025
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):